Cash flow Henan Lingrui Pharmaceutical Co., Ltd.

Equities

600285

CNE000001501

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-01-13			5-day change	1st Jan Change
21.16 ^CNY	-0.98%		-2.58%	+2.17%

25-10-29	Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-08-19	Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

6e.IZkuuPyiXzVT30gfpMYlCe1fOKa78ac4huFO0S4RqQg.dvVZwZPUb0chvDJWyYBRYqs2c8z8gMZf9q54uW9Fy1IY8Hj1lNdtZxXpEQ

Published financial data: HENAN LINGRUI PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.33B	2.69B	3B	3.31B	3.5B
Other Revenues, Total	3.44M	3.48M	3.44M	3.98M	2.73M
Total Revenues	2.33B	2.69B	3B	3.31B	3.5B
Cost of Goods Sold, Total	544M	708M	838M	889M	848M
Gross Profit	1.79B	1.99B	2.16B	2.42B	2.65B
Selling General & Admin Expenses, Total	1.34B	1.48B	1.61B	1.67B	1.76B
Provision for Bad Debts	-4.15M	2.07M	1.99M	4.64M	5.23M
R&D Expenses	97.76M	86.21M	125M	110M	132M
Other Operating Expenses	28.4M	37.4M	40.54M	44.84M	29.69M
Other Operating Expenses, Total	1.46B	1.61B	1.78B	1.83B	1.93B
Operating Income	324M	376M	389M	589M	724M
Interest Expense, Total	-1.1M	-1.9M	-1.14M	-198K	-256K
Interest And Investment Income	57.89M	43.03M	86.61M	55.87M	59.04M
Net Interest Expenses	56.79M	41.13M	85.47M	55.67M	58.78M
Currency Exchange Gains (Loss)	782	-1.38K	128	-8.3K	-58
Other Non Operating Income (Expenses)	-288K	-1.7M	-4.67M	-1.69M	-176K
EBT, Excl. Unusual Items	380M	416M	470M	643M	782M
Impairment of Goodwill	-500K	-	-	-	-
Gain (Loss) On Sale Of Investments	-52.06K	45.88K	5.93M	121K	-10.49K
Gain (Loss) On Sale Of Assets	-2.95M	-20.32M	-102K	-633K	-3.9M
Asset Writedown	-27.8M	-	-	-1.83M	-
Other Unusual Items	15.4M	17.74M	41.34M	12.49M	49.13M
EBT, Incl. Unusual Items	364M	413M	517M	653M	828M
Income Tax Expense	39.82M	50.85M	51.7M	84.93M	105M
Earnings From Continuing Operations	324M	362M	465M	568M	723M
Net Income to Company	324M	362M	465M	568M	723M
Minority Interest	1.11M	-957K	-370	-6.4K	-33.97K
Net Income - (IS)	325M	362M	465M	568M	723M
Net Income to Common Incl Extra Items	325M	362M	465M	568M	723M
Net Income to Common Excl. Extra Items	325M	362M	465M	568M	723M
Per Share Items
Net EPS - Basic	0.57	0.65	0.84	1.01	1.29
Basic EPS - Continuing Operations	0.57	0.65	0.84	1.01	1.29
Basic Weighted Average Shares Outstanding	568M	556M	557M	561M	561M
Net EPS - Diluted	0.57	0.64	0.82	1	1.28
Diluted EPS - Continuing Operations	0.57	0.64	0.82	1	1.28
Diluted Weighted Average Shares Outstanding	568M	567M	568M	566M	564M
Normalized Basic EPS	0.42	0.47	0.53	0.72	0.87
Normalized Diluted EPS	0.42	0.46	0.52	0.71	0.87
Dividend Per Share	0.4	0.5	0.6	0.8	0.9
Payout Ratio	55.03	61.91	62.07	60.6	62.47
Supplemental Items
EBITDA	392M	448M	463M	665M	795M
EBITA	334M	387M	400M	599M	735M
EBIT	324M	376M	389M	589M	724M
EBITDAR	397M	453M	468M	669M	800M
Total Revenues (As Reported)	2.33B	2.69B	3B	3.31B	3.5B
Effective Tax Rate - (Ratio)	10.93	12.3	10	13	12.69
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	58.89M	67.37M	85.29M	108M	105M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-19.07M	-16.51M	-33.58M	-23.09M	-221K
Normalized Net Income	239M	259M	294M	402M	489M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	363K	234K	256K
Non-Cash Pension Expense	135K	695K	-	-	-
Supplemental Operating Expense Items
Advertising Expense	357M	438M	-	265M	290M
Selling and Marketing Expenses	1.18B	1.3B	1.44B	1.5B	1.6B
General and Administrative Expenses	156M	183M	164M	171M	165M
Research And Development Expense From Footnotes	97.76M	86.21M	125M	110M	132M
Net Rental Expense, Total	4.92M	5.31M	4.88M	4.65M	4.65M
Imputed Operating Lease Interest Expense	195K	360K	202K	40.1K	62.16K
Imputed Operating Lease Depreciation	4.73M	4.95M	4.68M	4.61M	4.59M
Maintenance & Repair Expenses, Total	5.55M	6.2M	5.24M	3.1M	1.31M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	1.75M	698K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	12.32M	4.29M
Stock-Based Comp., Other (Total)	-	28.6M	37.62M	-	-
Total Stock-Based Compensation	-	28.6M	37.62M	14.07M	4.98M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	732M	801M	1.18B	1.5B	1.23B
Short Term Investments	40.08M	141M	125M	95.63M	283M
Trading Asset Securities, Total	57.23M	280M	150M	206K	-
Total Cash And Short Term Investments	830M	1.22B	1.46B	1.59B	1.51B
Accounts Receivable, Total	709M	431M	512M	499M	489M
Other Receivables	8.54M	9.58M	21.37M	19.35M	6.29M
Total Receivables	717M	441M	533M	518M	495M
Inventory	331M	428M	486M	467M	435M
Prepaid Expenses	380K	8.51K	-	-	-
Other Current Assets, Total	37.98M	39.87M	33.58M	18.51M	16.45M
Total Current Assets	1.92B	2.13B	2.51B	2.6B	2.46B
Gross Property Plant And Equipment	1.09B	1.15B	1.19B	1.19B	1.23B
Accumulated Depreciation	-362M	-421M	-484M	-541M	-594M
Net Property Plant And Equipment	730M	733M	707M	648M	631M
Long-term Investments	350M	365M	349M	1.07B	1.44B
Goodwill	-	-	-	-	-
Other Intangibles, Total	235M	237M	204M	203M	204M
Deferred Tax Assets Long-Term	97.79M	116M	159M	187M	200M
Deferred Charges Long-Term	87.15M	65.53M	51.54M	36.73M	12.34M
Other Long-Term Assets, Total	41.45M	145M	367M	29.98M	74.45M
Total Assets	3.46B	3.79B	4.34B	4.77B	5.02B
Liabilities
Accounts Payable, Total	78.81M	78.01M	68.02M	57.38M	85.13M
Accrued Expenses, Total	528M	600M	918M	1.11B	1.18B
Short-term Borrowings	166M	272M	151M	200M	90.47M
Current Portion of Leases	-	1.65M	1.22M	1.08M	1.78M
Current Income Taxes Payable	52.46M	46.9M	55.54M	70.72M	56.28M
Unearned Revenue Current, Total	71.73M	79.09M	154M	114M	114M
Other Current Liabilities	169M	359M	364M	347M	350M
Total Current Liabilities	1.07B	1.44B	1.71B	1.9B	1.87B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	7.9M	6.2M	6.96M	6.55M
Unearned Revenue Non Current	48.26M	42.78M	38.55M	39.78M	33.4M
Deferred Tax Liability Non Current	21.09M	18.18M	29.22M	26.32M	22.27M
Total Liabilities	1.14B	1.51B	1.79B	1.97B	1.94B
Common Stock, Total	568M	568M	567M	567M	567M
Additional Paid In Capital	306M	272M	310M	326M	341M
Retained Earnings	1.34B	1.48B	1.66B	1.89B	2.18B
Treasury Stock	-	-98.19M	-67.62M	-47.4M	-13.7M
Comprehensive Income and Other	98.31M	56.08M	76.74M	51M	-2.02M
Total Common Equity	2.31B	2.28B	2.55B	2.79B	3.07B
Minority Interest	9.43M	7.59M	7.55M	7.66M	7.77M
Total Equity	2.32B	2.29B	2.56B	2.8B	3.08B
Total Liabilities And Equity	3.46B	3.79B	4.34B	4.77B	5.02B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	562M	565M	570M	564M	564M
ECS Total Common Shares Outstanding	568M	565M	570M	564M	564M
Book Value / Share	4.07	4.04	4.48	4.95	5.44
Tangible Book Value	2.08B	2.04B	2.35B	2.59B	2.87B
Tangible Book Value Per Share	3.66	3.62	4.12	4.59	5.08
Total Debt	166M	282M	159M	208M	98.8M
Net Debt	-664M	-940M	-1.3B	-1.39B	-1.41B
Debt Equivalent Oper. Leases	39.38M	42.47M	39.05M	37.2M	37.2M
Minority Interest, Total (Incl. Fin. Div)	9.43M	7.59M	7.55M	7.66M	7.77M
Equity Method Investments, Total	98.58M	117M	71.65M	71.27M	73.09M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	185M	193M	218M	192M	177M
Inventories - Work In Process, Total	61.65M	117M	171M	172M	148M
Inventories - Finished Goods, Total	85.13M	128M	106M	109M	110M
Buildings, Total	578M	583M	595M	594M	588M
Machinery, Total	512M	535M	582M	582M	592M
Full Time Employees	2.6K	2.5K	2.52K	2.53K	2.44K
Accumulated Allowance for Doubtful Accounts (Supple)	11.11M	12.69M	14.42M	18.93M	20.85M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	325M	362M	465M	568M	723M
Depreciation & Amortization - CF	58.13M	61.77M	65.12M	67.74M	62.56M
Amortization of Goodwill and Intangible Assets - (CF)	10.33M	11.03M	11.13M	9.88M	10.98M
Depreciation & Amortization, Total	68.46M	72.8M	76.25M	77.62M	73.54M
Amortization of Deferred Charges, Total - (CF)	4.86M	3.92M	2.81M	4.89M	2.69M
(Gain) Loss From Sale Of Asset	-79.48K	-34.62K	-24.59K	-47.65K	-12.06K
(Gain) Loss on Sale of Investments - (CF)	-41.16M	-30.6M	-64.58M	-20.28M	-40.2M
Asset Writedown & Restructuring Costs	30.83M	20.36M	127K	2.52M	3.91M
Provision and Write-off of Bad Debts	-4.15M	2.07M	1.99M	4.64M	5.23M
Other Operating Activities, Total	5.4M	12.17M	5.82M	3.83M	1.69M
Change In Accounts Receivable	-70.53M	236M	-76.41M	-43.44M	17.41M
Change In Inventories	-44.51M	-106M	-58.19M	26.9M	31.88M
Change In Accounts Payable	195M	261M	478M	198M	52.43M
Change In Deferred Taxes	-19.07M	-16.51M	-33.58M	-23.09M	-221K
Change in Other Net Operating Assets	-	28.6M	37.62M	14.07M	4.98M
Cash from Operations	451M	846M	835M	813M	876M
Capital Expenditure	-71.82M	-76.91M	-26.99M	-21.2M	-115M
Sale of Property, Plant, and Equipment	204K	474K	12.23M	10.15M	17.85K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	75.67M	-483M	-83.02M	-232M	-571M
Other Investing Activities, Total	7.82M	13.63M	13.97M	13.3M	20.16M
Cash from Investing	11.87M	-546M	-83.81M	-230M	-666M
Short Term Debt Issued, Total	172M	236M	90M	103M	40.43M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	172M	236M	90M	103M	40.43M
Short Term Debt Repaid, Total	-287M	-130M	-170M	-20M	-103M
Long-Term Debt Repaid, Total	-	-1.68M	-2.28M	-1.89M	-1.86M
Total Debt Repaid	-287M	-132M	-172M	-21.89M	-105M
Issuance of Common Stock	-	75.91M	-	-	35.14M
Repurchase of Common Stock	-	-184M	-1.85M	-787K	-85.1K
Common Dividends Paid	-179M	-224M	-289M	-344M	-451M
Common & Preferred Stock Dividends Paid	-179M	-224M	-289M	-344M	-451M
Other Financing Activities, Total	-12.09M	-3.09M	-120K	-8.62M	8.62M
Cash from Financing	-306M	-231M	-373M	-273M	-472M
Foreign Exchange Rate Adjustments	-95.19K	-26.69K	35.99K	-2.37K	7.77K
Net Change in Cash	156M	68.93M	378M	311M	-262M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	315M	357M	395M	477M	493M
Levered Free Cash Flow	269M	704M	584M	632M	559M
Unlevered Free Cash Flow	270M	705M	584M	632M	559M
Change In Net Working Capital	-65.88M	-441M	-252M	-189M	-140M
Net Debt Issued / Repaid	-115M	105M	-82.28M	80.96M	-64.27M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.97	6.49	5.98	8.07	9.24
Return on Total Capital	8.11	9.31	9.2	12.86	14.63
Return On Equity %	14.28	15.73	19.21	21.21	24.58
Return on Common Equity	14.39	15.75	19.27	21.27	24.65
Margin Analysis
Gross Profit Margin %	76.67	73.72	72.1	73.17	75.77
SG&A Margin	57.56	55.07	53.56	50.58	50.34
EBITDA Margin %	16.82	16.62	15.44	20.07	22.72
EBITA Margin %	14.32	14.39	13.33	18.08	20.99
EBIT Margin %	13.88	13.98	12.96	17.78	20.67
Income From Continuing Operations Margin %	13.91	13.46	15.5	17.16	20.64
Net Income Margin %	13.96	13.42	15.5	17.16	20.64
Net Avail. For Common Margin %	13.96	13.42	15.5	17.16	20.64
Normalized Net Income Margin	10.24	9.61	9.78	12.13	13.97
Levered Free Cash Flow Margin	11.53	26.13	19.45	19.09	15.96
Unlevered Free Cash Flow Margin	11.56	26.17	19.47	19.09	15.97
Asset Turnover
Asset Turnover	0.69	0.74	0.74	0.73	0.72
Fixed Assets Turnover	3.12	3.68	4.17	4.89	5.47
Receivables Turnover (Average Receivables)	3.44	4.72	6.36	6.54	7.08
Inventory Turnover (Average Inventory)	1.76	1.86	1.83	1.86	1.88
Short Term Liquidity
Current Ratio	1.8	1.48	1.47	1.37	1.31
Quick Ratio	1.45	1.16	1.16	1.11	1.07
Operating Cash Flow to Current Liabilities	0.42	0.59	0.49	0.43	0.47
Days Sales Outstanding (Average Receivables)	106.34	77.33	57.41	55.78	51.68
Days Outstanding Inventory (Average Inventory)	207.94	195.86	199.34	195.9	194.64
Average Days Payable Outstanding	45.53	35.55	29.76	26.32	31.96
Cash Conversion Cycle (Average Days)	268.75	237.63	226.98	225.36	214.36
Long Term Solvency
Total Debt/Equity	7.15	12.33	6.2	7.43	3.21
Total Debt / Total Capital	6.67	10.98	5.84	6.92	3.11
LT Debt/Equity	-	0.35	0.24	0.25	0.21
Long-Term Debt / Total Capital	-	0.31	0.23	0.23	0.21
Total Liabilities / Total Assets	32.84	39.72	41.11	41.35	38.6
EBIT / Interest Expense	293.15	198.53	341.97	2.98K	2.82K
EBITDA / Interest Expense	355.17	236.92	408.99	3.37K	3.11K
(EBITDA - Capex) / Interest Expense	290.11	196.36	385.26	3.26K	2.66K
Total Debt / EBITDA	0.42	0.63	0.34	0.31	0.12
Net Debt / EBITDA	-1.69	-2.09	-2.79	-2.08	-1.77
Total Debt / (EBITDA - Capex)	0.52	0.76	0.36	0.32	0.14
Net Debt / (EBITDA - Capex)	-2.07	-2.53	-2.96	-2.15	-2.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.09	15.52	11.45	10.31	5.72
Gross Profit, 1 Yr. Growth %	7.45	11.3	9	11.95	9.47
EBITDA, 1 Yr. Growth %	-1.06	16.37	3.52	43.45	19.67
EBITA, 1 Yr. Growth %	-1.46	18.67	3.28	49.63	22.7
EBIT, 1 Yr. Growth %	-1.55	19.05	3.35	51.37	22.89
Earnings From Cont. Operations, 1 Yr. Growth %	10.66	11.75	28.37	22.1	27.19
Net Income, 1 Yr. Growth %	10.55	11.08	28.71	22.09	27.19
Normalized Net Income, 1 Yr. Growth %	14.72	8.52	13.4	35.98	21.68
Diluted EPS Before Extra, 1 Yr. Growth %	11.91	11.34	28.37	22.47	27.72
Accounts Receivable, 1 Yr. Growth %	9.98	-39.15	18.74	-2.53	-2.01
Inventory, 1 Yr. Growth %	15.6	29.26	13.54	-3.92	-6.93
Net Property, Plant and Equip., 1 Yr. Growth %	-4.7	0.4	-3.57	-8.34	-2.56
Total Assets, 1 Yr. Growth %	4.28	9.7	14.53	9.84	5.13
Tangible Book Value, 1 Yr. Growth %	5.61	-1.72	14.95	10.28	10.83
Common Equity, 1 Yr. Growth %	4.65	-1.46	11.93	9.42	10.09
Cash From Operations, 1 Yr. Growth %	0.08	87.71	-1.27	-2.57	7.68
Capital Expenditures, 1 Yr. Growth %	21.65	7.08	-64.9	-21.47	443.02
Levered Free Cash Flow, 1 Yr. Growth %	13.27	166.26	-13.54	15.73	-9.58
Unlevered Free Cash Flow, 1 Yr. Growth %	10.66	166.02	-13.59	15.6	-9.57
Dividend Per Share, 1 Yr. Growth %	33.33	25	20	33.33	12.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.57	11.75	13.47	10.88	7.99
Gross Profit, 2 Yr. CAGR %	7.19	9.24	10.15	10.47	10.7
EBITDA, 2 Yr. CAGR %	4	6.28	9.76	21.86	31.02
EBITA, 2 Yr. CAGR %	4.75	6.93	10.71	24.31	35.5
EBIT, 2 Yr. CAGR %	4.9	7.02	10.93	25.08	36.39
Earnings From Cont. Operations, 2 Yr. CAGR %	14.89	11.2	19.77	25.19	24.62
Net Income, 2 Yr. CAGR %	15.67	10.81	19.57	25.35	24.61
Normalized Net Income, 2 Yr. CAGR %	16.25	11.57	10.93	24.56	28.63
Diluted EPS Before Extra, 2 Yr. CAGR %	17.93	11.63	19.55	25.38	25.06
Accounts Receivable, 2 Yr. CAGR %	12.41	-18.19	-15	7.58	-2.27
Inventory, 2 Yr. CAGR %	1.17	22.24	21.15	4.45	-5.44
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.26	-2.19	-1.61	-5.99	-5.5
Total Assets, 2 Yr. CAGR %	5.44	6.96	12.09	12.16	7.46
Tangible Book Value, 2 Yr. CAGR %	6.54	1.88	6.29	12.59	10.55
Common Equity, 2 Yr. CAGR %	5.39	1.55	5.02	10.67	9.75
Cash From Operations, 2 Yr. CAGR %	1.62	37.06	36.13	-1.93	2.42
Capital Expenditures, 2 Yr. CAGR %	17.36	14.13	-38.69	-47.5	106.5
Levered Free Cash Flow, 2 Yr. CAGR %	29.93	72.17	48.61	-3.25	1.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.13	70.09	48.51	-3.32	1.1
Dividend Per Share, 2 Yr. CAGR %	63.3	29.1	22.47	26.49	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.05	9.47	11.65	12.41	9.13
Gross Profit, 3 Yr. CAGR %	9.93	8.47	9.16	10.75	10.13
EBITDA, 3 Yr. CAGR %	9.65	7.29	5.36	20	21.13
EBITA, 3 Yr. CAGR %	9.09	8.38	5.7	22.4	23.77
EBIT, 3 Yr. CAGR %	9.39	8.58	5.78	23.04	24.34
Earnings From Cont. Operations, 3 Yr. CAGR %	12.98	13.83	16.65	20.54	25.85
Net Income, 3 Yr. CAGR %	14.45	14.12	16.48	20.4	25.96
Normalized Net Income, 3 Yr. CAGR %	16.9	13.61	12.18	18.97	23.59
Diluted EPS Before Extra, 3 Yr. CAGR %	16.01	15.69	16.95	20.52	26.16
Accounts Receivable, 3 Yr. CAGR %	7.44	-8.39	-7.38	-11.03	4.28
Inventory, 3 Yr. CAGR %	-3.17	9.78	19.27	12.14	0.51
Net Property, Plant and Equip., 3 Yr. CAGR %	-3.3	-2.06	-2.65	-3.9	-4.86
Total Assets, 3 Yr. CAGR %	1.49	6.84	9.42	11.34	9.77
Tangible Book Value, 3 Yr. CAGR %	2.88	3.72	6.06	7.6	12
Common Equity, 3 Yr. CAGR %	2.08	3.06	4.9	6.47	10.47
Cash From Operations, 3 Yr. CAGR %	62	24.69	22.86	21.77	1.18
Capital Expenditures, 3 Yr. CAGR %	-34.67	13.83	-22.96	-33.42	14.39
Levered Free Cash Flow, 3 Yr. CAGR %	225.36	64.08	34.97	33.72	-6.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	932.63	60.83	33.86	33.61	-6.16
Dividend Per Share, 3 Yr. CAGR %	38.67	49.38	25.99	25.99	21.64
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.54	13.35	10.18	10.03	10.17
Gross Profit, 5 Yr. CAGR %	21.46	15.56	9.97	9.26	9.78
EBITDA, 5 Yr. CAGR %	17.76	15.77	9.27	12.9	14.96
EBITA, 5 Yr. CAGR %	18.71	16.76	9.25	14.49	16.74
EBIT, 5 Yr. CAGR %	18.92	16.92	9.49	14.9	17.1
Earnings From Cont. Operations, 5 Yr. CAGR %	19.51	0.84	15.65	18.25	19.77
Net Income, 5 Yr. CAGR %	19.8	0.9	16.47	18.49	19.67
Normalized Net Income, 5 Yr. CAGR %	19.81	0.14	14.47	17.87	18.64
Diluted EPS Before Extra, 5 Yr. CAGR %	18.43	1.13	17.42	19.48	20.13
Accounts Receivable, 5 Yr. CAGR %	30	5.37	-2.17	-2.31	-5.37
Inventory, 5 Yr. CAGR %	2.14	-2.41	5.91	7.61	8.7
Net Property, Plant and Equip., 5 Yr. CAGR %	6.46	1.81	-2.62	-3.65	-3.8
Total Assets, 5 Yr. CAGR %	4.07	4.93	5.6	8.94	8.63
Tangible Book Value, 5 Yr. CAGR %	5.27	0.89	4.23	7.18	7.84
Common Equity, 5 Yr. CAGR %	6.03	1.78	3.25	6.04	6.81
Cash From Operations, 5 Yr. CAGR %	14.85	67.96	51.11	13.27	14.24
Capital Expenditures, 5 Yr. CAGR %	-5.91	-18.81	-36.31	-16.47	14.29
Levered Free Cash Flow, 5 Yr. CAGR %	23.26	16.57	136.99	31.73	18.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.64	17.15	373.76	30.12	18.06
Dividend Per Share, 5 Yr. CAGR %	-	10.76	31.95	39.77	24.57